Filling Dangerous Cracks in the Pharmaceutical Supply Chain
By Reginaldo Montague, CFPIM, CSCPDownload PDF Prescription for Product Safety
APICS magazine (September/October 2016)
With 80 percent of the active pharmaceutical ingredients in U.S. drugs originating from outside the country, the risk of a tainted supply chain is higher than ever—and the results can be deadly. Counterfeit and adulterated drugs are a rising problem, and although the FDA is working to better regulate the supply chain, the threat is real.
In an article published in APICS magazine, IPM’s Reg Montague discusses this growing problem and how the pharmaceutical industry is joining forces to address it.
Service: Supply Chain Optimization
Industry: Life Sciences
— Published October 21, 2016